- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07298213
Corazones Unidos Study
December 11, 2025 updated by: University of Arizona
Pilot Test of Su Corazon Su Vida Among Mexican Origin Adults With MASLD
CVD is the leading cause of death among individuals with MASLD, a risk factor for liver cancer.
In Southern Arizona, CVD and cancer (including liver and gastric cancer) are among the leading causes of death for Mexican-origin adults.1 Given Mexican-origin adults' disproportionate burden of CVD-related mortality37 and higher rates of MASLD compared to other ethnic/racial groups; we urgently need to develop contextually tailored strategies for management of CVD risk factors and outcomes.
Thus, the purpose of this study is to examine the acceptability and feasibility of a community health worker (CHW)-led intervention aimed to increase cardiovascular risk awareness and promote lifestyle modifications among Mexican-origin adults with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in the Southern Arizona region.
The proposed project has the potential to improve health outcomes for this vulnerable population and contribute to the ACS-CHERC's overarching goal of improving health equity for Hispanic communities and family caregivers.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Adriana Maldonado Assistant Professor, PhD
- Phone Number: 5206267279
- Email: adrianamaldonado@arizona.edu
Study Contact Backup
- Name: Edgar Villavicencio A Research Coordinator, MPH
- Phone Number: 5206264745
- Email: evillavicencio@arizona.edu
Study Locations
-
-
Arizona
-
Tucson, Arizona, United States, 85714
- Recruiting
- UA Collaboratory for Metabolic Disease Prevention & Treatment
-
Contact:
- Adriana Maldonado Assistant Professor, PhD
- Phone Number: 5206264641
- Email: adrianamaldonado@arizona.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Eligible intervention participants must (1) be Mexican-origin/Mexican decent, (2) be ≥ 18 years old, (3) have a confirmed MASLD diagnosis (CAP score of ≥ 248 dB/m); (4) have an adult member of their social network who might be interested in participating in the study and who lives within 25 miles of the participant's residence; (5) be able to provide informed consent; and (6) be able to speak, read, and write in English and/or Spanish. Eligible social support participants must (1) be ≥ 18 years old, (2) be first degree blood relative or spouse/significant other to the intervention participants, (3) be able to provide informed consent; and (4) be able to speak, read, and write in English and/or Spanish.
Exclusion Criteria:
- Exclusion for individuals interested in the intervention component of the study will be excluded if they report (1) ongoing or recent alcohol consumption (≥21 standard drinks on average per week in men and ≥14 standard drinks on average per week in women); (2) previous diagnosis of liver cancer; (3) taking any anti-inflammatory or hepatoxic medication regularly; (4) taking medication for any form of psychiatric disorders; (5) diagnosis of depression; (6) diagnosis of autoimmune disorders; or (7) women who are pregnant or breastfeeding due to hormonal changes. Exclusion for those interested to be part of the study as social network participants will not be considered for participation if they (1) live more than 25 miles of the intervention participant's residence.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Corazones Unidos
"Corazones Unidos" will be delivered over 12 weekly in-person 60-minute sessions to dyads (consisting on both, intervention and social network participants) in community-based settings.
|
Trained CHWs will facilitate educational sessions where participants will learn about heart-healthy behaviors, heart attack symptoms, heart-healthy eating for Hispanic families, and risk factors for both CVD and MASLD.
Participants will also be taught behavioral change techniques including goal setting, problem solving, and relapse prevention.
Specifically, participants will be asked to collaborate in selecting specific lifestyle goals and to develop shared strategies for improving adherence to their goals, overcoming barriers, and providing support to address potential relapses.
Curriculum content will be supplemented by a variety of approaches designed to motivate behavior change including videos, role play, and low-literacy culturally appropriate brochures published by NHLBI.
|
|
Active Comparator: Su Corazon, Su Vida
"Su Corazón, Su Vida" group will receive the standard 12-week evidence-based curriculum as a group in a community setting; however, with no peer support provided.
|
Trained CHWs will facilitate educational sessions where participants will learn about heart-healthy behaviors, heart attack symptoms, heart-healthy eating for Hispanic families, and risk factors for both CVD and MASLD.
Participants will also be taught behavioral change techniques including goal setting, problem solving, and relapse prevention.
Specifically, participants will be asked to collaborate in selecting specific lifestyle goals and to develop shared strategies for improving adherence to their goals, overcoming barriers, and providing support to address potential relapses.
Curriculum content will be supplemented by a variety of approaches designed to motivate behavior change including videos, role play, and low-literacy culturally appropriate brochures published by NHLBI.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cardiovascular Health
Time Frame: Baseline, 12 weeks, and 24 weeks
|
A composite score modeled after the American Heart Association Life's Essential Eight will be computed.
Independent scores for diet, physical activity, nicotine exposure, sleep health, body mass index, blood lipids, blood glucose, and blood pressure will be calculated and then transformed into a graded score ranging from 0 (worst) to 100 (best).
|
Baseline, 12 weeks, and 24 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 18, 2025
Primary Completion (Estimated)
July 17, 2026
Study Completion (Estimated)
July 17, 2026
Study Registration Dates
First Submitted
December 11, 2025
First Submitted That Met QC Criteria
December 11, 2025
First Posted (Actual)
December 23, 2025
Study Record Updates
Last Update Posted (Actual)
December 23, 2025
Last Update Submitted That Met QC Criteria
December 11, 2025
Last Verified
June 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00006222
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on CVD - Cardiovascular Disease
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)RecruitingCVD - Cardiovascular DiseaseUnited States
-
Western Galilee Hospital-NahariyaLuoxisCompletedCardiovascular Disease (CVD)Israel
-
University of PennsylvaniaNational Institutes of Health (NIH); Geisinger Clinic; Harvard Vanguard Medical...CompletedCardiovascular Disease (CVD)United States
-
University of PennsylvaniaCompletedCancer | Cardiovascular Disease (CVD)United States
-
University of North Carolina, Chapel HillCenters for Disease Control and PreventionCompletedCardiovascular Disease (CVD)United States
-
Oregon Health and Science UniversityNational Heart, Lung, and Blood Institute (NHLBI)Not yet recruitingCardiovascular Disease (CVD) Risk FactorsUnited States
-
Kaiser PermanenteAgency for Healthcare Research and Quality (AHRQ)CompletedCardiovascular Disease (CVD) Risk FactorsUnited States
-
Samsung Medical CenterRecruitingCerebro Vascular Disease | Cardiovascular Diseases (CVD)South Korea
-
Weill Medical College of Cornell UniversityAmerican Heart AssociationRecruitingCardiovascular | Cardiovascular Health | Cardiovascular (CV) Risk | Cardiovascular Disease (CVD) Risk FactorsUnited States
-
Children's Hospital Medical Center, CincinnatiRecruitingCardiovascular Diseases (CVD)United States
Clinical Trials on Your Heart, Your Health
-
University of South CarolinaCenters for Disease Control and PreventionNot yet recruitingHealthy Participants | Chronic Disease Prevention | Chronic Diseases in Older AdultsUnited States
-
University of MichiganNational Institute on Minority Health and Health Disparities (NIMHD)CompletedCardiovascular Risk FactorsUnited States
-
George Washington UniversityNational Heart, Lung, and Blood Institute (NHLBI)RecruitingPhysical Activity | Sleep | Diet, Healthy | Nicotine | Obesity & Overweight | Cardio Vascular DiseaseUnited States
-
University of Southern DenmarkRegion of Southern Denmark; Odense Patient Data Explorative Network; ENIGMA Solutions... and other collaboratorsActive, not recruitingCardiovascular Risk Factor | Risk CommunicationDenmark
-
University of CalgaryCompletedCoronary Artery Disease | Acute Coronary SyndromeCanada
-
University Hospital, BordeauxNot yet recruitingCHD - Congenital Heart DiseaseFrance
-
University of Illinois at ChicagoNational Institute on Disability, Independent Living, and Rehabilitation...Active, not recruiting
-
Ohio State University Comprehensive Cancer CenterNational Institute on Minority Health and Health Disparities (NIMHD)CompletedRectal Cancer | Colon CancerUnited States
-
West Park Healthcare CentreCompleted